Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MUC1 Antibody-Based Therapeutics: The Promise of Cancer Immunotherapy
Mona Pourjafar, Pouria Samadi, Massoud Saidijam
Immunotherapy (2020) Vol. 12, Iss. 17, pp. 1269-1286
Closed Access | Times Cited: 16

Showing 16 citing articles:

MUC1: Structure, Function, and Clinic Application in Epithelial Cancers
Wenqing Chen, Zhu Zhang, Shiqing Zhang, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6567-6567
Open Access | Times Cited: 161
A review on targeting tumor microenvironment: The main paradigm shift in the mAb-based immunotherapy of solid tumors
Ayuob Aghanejad, Samad Farashi Bonab, Maryam Sepehri, et al.
International Journal of Biological Macromolecules (2022) Vol. 207, pp. 592-610
Closed Access | Times Cited: 59
Targeted Drug Delivery Using a Plug-to-Direct Antibody–Nanogel Conjugate
Uyen Huynh, Peidong Wu, Jingyi Qiu, et al.
Biomacromolecules (2023) Vol. 24, Iss. 2, pp. 849-857
Open Access | Times Cited: 12
MUC1-Targeted Radiopharmaceuticals in Cancer Imaging and Therapy
Fariba Maleki, Farzaneh Rezazadeh, Kambiz Varmira
Molecular Pharmaceutics (2021) Vol. 18, Iss. 5, pp. 1842-1861
Closed Access | Times Cited: 21
Suppression of MUC1-Overexpressing Tumors by a Novel MUC1/CD3 Bispecific Antibody
Jun Fang, Shifa Lai, Haoyang Yu, et al.
Antibodies (2023) Vol. 12, Iss. 3, pp. 47-47
Open Access | Times Cited: 7
Development of CAR-T Therapies and Personalized Vaccines for the Treatment of Cholangiocarcinoma: Current Progress, Mechanisms of Action, and Challenges
Dan Li, Lalitya Andaloori, Matthew Crowe, et al.
American Journal Of Pathology (2024)
Closed Access | Times Cited: 2
The Risk of Gastrointestinal Cancer on Daily Intake of Low-Dose BaP in C57BL/6 for 60 Days
Zhi Zheng, Jung Kuk Park, Oh Wook Kwon, et al.
Journal of Korean Medical Science (2022) Vol. 37, Iss. 30
Open Access | Times Cited: 12
Advances in MUC1-Mediated Breast Cancer Immunotherapy
Li Z, Dazhuang Yang, Ting Guo, et al.
Biomolecules (2022) Vol. 12, Iss. 7, pp. 952-952
Open Access | Times Cited: 9
Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy Against Thoracic Malignancies: Challenges and Opportunities
Long Chen, Fukun Chen, Huatao Niu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Surfaceome Profiling Suggests Potential of Anti-MUC1×EGFR Bispecific Antibody for Breast Cancer Targeted Therapy
Mona Pourjafar, Massoud Saidijam, Michaela Miehe, et al.
Journal of Immunotherapy (2023) Vol. 46, Iss. 7, pp. 245-261
Closed Access | Times Cited: 4
Targeted Gene-Hormone Therapy of Colorectal Cancer with Guanylin Expressing Nano-system
Pouria Samadi, Fatemeh Rahbarizadeh, Fatemeh Nouri, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Advances in MUC1 resistance to chemotherapy in pancreatic cancer
Youhao Yao, Daguang Fan
Journal of Chemotherapy (2023) Vol. 36, Iss. 6, pp. 449-456
Open Access | Times Cited: 2
Targeted Gene-Hormone Therapy of Colorectal Cancer with Guanylin Expressing Nano-system: In Silico and In Vitro Study
Pouria Samadi, Fatemeh Rahbarizadeh, Fatemeh Nouri, et al.
Research Square (Research Square) (2024)
Closed Access
Progress in the Utilization of Nanobody CAR-T Cell in Cancer Immunotherapy
Qian Jiang, Wei Shi, Heng Liu, et al.
Journal of Biomedical Nanotechnology (2024) Vol. 20, Iss. 8, pp. 1207-1224
Closed Access
Preliminary study on the improvement of identifying effect of Tc-99 m labeled C595 monoclonal antibody in MUC1 imaging of ovarian cancer
Yan Zhang, Yuzhen Feng, Mei Zhang, et al.
Journal of Radioanalytical and Nuclear Chemistry (2022) Vol. 331, Iss. 10, pp. 4189-4195
Closed Access
Computational Design for Identification of Human Anti-MUC1 Heteroclitic Peptides in the Treatment of HER2-Positive Breast Cancer through Neural Network Training and Monomeric based Design
Anil Kumar Chhillar, Akanksha Behl, Nagendra Nath Das, et al.
Current Cancer Drug Targets (2022) Vol. 23, Iss. 3, pp. 235-241
Closed Access
Page 1

Scroll to top